PGT-A Preimplantation Genetic Testing for Aneuploidies

PGT-A (formerly called PGS) is a genetic test performed on embryos to identify numerical chromosomal abnormalities (aneuploidy).
This test is a genetic study of the embryo produced during IVF treatment and can help you have a healthy baby.

Reduced miscarriage rates – the vast majority of which are due to aneuploidy
Higher pregnancy rates per transfer – selecting normal embryos can increase the pregnancy chances
Fewer cycles of IVF treatment needed, reducing both the time and financial cost
Greater chance of having a healthy child – some pregnancies with chromosomal anomalies can give rise to the birth of baby with a serious illness
Fewer ‘wasted’ transfers (implantation failure) with aneuploid embryos that could never lead to a successful pregnancy
Optional Single Embryo Transfer (SET) to significantly reduce the likelihood of a multiple-gestation pregnancy (twin pregnancy)

PGT-A is especially recommended for patients with:

Advanced maternal age: 35 years old and above
Recurrent miscarriages: couples who have had two or more miscarriages in the past
IVF failures: two or more failures during IVF treatment cicles
Male factor infertility: a low quantity and/or quality of sperm

Other services

EMMA

Evaluates the endometrium at the microbiological level

Avoid implantation failure by establishing the best day and time for embryo transfer

ALICE

Detects the bacteria causing chronic endometritis